Brain: normal variations and benign findings in fluorodeoxyglucose-PET/computed tomography imaging
- PMID: 24772054
- PMCID: PMC3998066
- DOI: 10.1016/j.cpet.2013.10.006
Brain: normal variations and benign findings in fluorodeoxyglucose-PET/computed tomography imaging
Abstract
Brain 18F-fluorodeoxyglucose (18F-FDG) PET allows the in vivo study of cerebral glucose metabolism, reflecting neuronal and synaptic activity. 18F-FDG-PET has been extensively used to detect metabolic alterations in several neurologic diseases compared with normal aging. However, healthy subjects have variants of 18F-FDG distribution, especially as associated with aging. This article focuses on 18F-FDG-PET findings in so-called normal brain aging, and in particular on metabolic differences occurring with aging and as a function of people’s gender. The effect of different substances, medications, and therapy procedures are discussed, as well as common artifacts.
Figures
References
-
- Sokoloff L, Reivich M, Kennedy C, et al. THE [14C]DEOXYGLUCOSE METHOD FOR THE MEASUREMENT OF LOCAL CEREBRAL GLUCOSE UTILIZATION: THEORY, PROCEDURE, AND NORMAL VALUES IN THE CONSCIOUS AND ANESTHETIZED ALBINO RAT. Journal of Neurochemistry. 1977;28:897–916. - PubMed
-
- Sokoloff L. Energetics of functional activation in neural tissues. Neurochem Res. 1999;24(2):321–329. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical